SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-052712
Filing Date
2021-04-20
Accepted
2021-04-20 19:49:31
Documents
2
Period of Report
2021-04-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2113501-5_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2113501-5_3seq1.xml 3 2218
2 EXHIBIT 24.1 tm2113501d5_ex24-1.htm EX-24.1 10578
  Complete submission text file 0001104659-21-052712.txt   14211
Mailing Address C/O MIRNA THERAPEUTICS, INC. 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address
Winkler Matthew (Reporting) CIK: 0001652067 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40344 | Film No.: 21839179

Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Issuer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments